Overview: In May 2021 United States' Unpackaged Medicaments exports accounted up to $134M and imports accounted up to $52.9M, resulting in a positive trade balance of $81.4M. Between May 2020 and May 2021 the exports of United States' Unpackaged Medicaments have decreased by $-7.58M (-5.34%) from $142M to $134M, while imports decreased by $-5.36M (-9.2%) from $58.3M to $52.9M.
Destinations: In May 2021, Unpackaged Medicaments were exported mostly to Ireland ($44.1M), Germany ($37.7M), Canada ($10.6M), United Kingdom ($9.35M), and Switzerland ($7.56M), and were imported mostly from Portugal ($12.1M), Germany ($9.34M), China ($7.41M), Ireland ($5.74M), and India ($5.18M).
Growth: In May 2021, the decrease in Unpackaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to Ireland ($-25.8M or -36.9%), Sweden ($-10.7M or -95.6%), and Italy ($-3.65M or -99.6%). In May 2021, the decrease in Unpackaged Medicaments's year-by-year imports was explained primarily by a decrease in imports from Ireland ($-12.7M or -68.9%), Italy ($-5.35M or -92.7%), and South Korea ($-2.19M or -97.4%).